ReviewWorld journal of gastroenterology2020
Hepatic hemangioma: What internists need to know.
Review in World journal of gastroenterology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
55 citing papers in PubMed, 1 synthesis or guideline pooled it, 85 citations in OpenAlex.
- A Comprehensive Review of Hepatic Hemangioma Management.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2022Pooled it
- Management and Clinical Outcomes of Liver Hemangiomas: A Retrospective Comparative Study of Transcatheter Arterial Embolization and Surgery.Medicina (Kaunas, Lithuania) · 2026Article
- Association of endogenous hypercortisolism with hepatic hemangiomas in cushing's disease: a retrospective cohort study.BMC endocrine disorders · 2026Observational
- Giant Cavernous Hepatic Hemangioma Masking a Separate Pleural Empyema: A Diagnostic Pitfall and Anchoring Bias.Cureus · 2026Article
- Hepatic cavernous hemangioma decellularized extracellular matrix/GelMA composite hydrogel promotes angiogenesis via the ITGA9-FAK-ERK1/2 axis.Materials today. Bio · 2026Article
- Frequency and associated factors of hepatic hemangioma in systemic lupus erythematosus patients undergoing abdominal imaging: a retrospective cohort study.Rheumatology international · 2026Article
- Comparison of perioperative outcomes between robotic-assisted and open resection for hepatic caudate lobe hemangioma: a single-center retrospective study.Surgical endoscopy · 2026Article
- Article
- Safety and feasibility of laparoscopic resection for giant hepatic hemangiomas: a retrospective cohort study.BMC surgery · 2026Article
- Gradual spontaneous regression of hepatic hemangioma in a woman with surgical menopause: A decade of imaging follow-up.Radiology case reports · 2026Article
- Breast Hemangioma with Slow Growth over 11 Years: A Case Report.Reports (MDPI) · 2026Article
- Performance of [European journal of nuclear medicine and molecular imaging · 2026Article
- Hepatic Haemangioma Mimicking an Abscess in a Young Female: An Atypical Presentation of SLE.Cureus · 2025Article
- Focal Hyperechoic Hepatic Lesions in Northern Region of Saudi Arabia: Prevalence, Radiologic Features, and Clinical Relevance.Journal of clinical medicine · 2025Article
- Giant hepatic hemangioma in a Japanese adult patient reduced by sirolimus therapy.Clinical journal of gastroenterology · 2025Article
- Resistant Hilar Stricture Following Transarterial Bleomycin-Lipiodol Embolization for a Large Hepatic Hemangioma.ACG case reports journal · 2025Article
- Improving ultrasound image classification accuracy of liver tumors using deep learning model with hepatitis virus infection information.Journal of medical ultrasonics (2001) · 2025Article
- A novel and effective strategy for the treatment of large hepatic hemangioma: combining preoperative embolization with laparoscopic-assisted and ultrasound-guided ablation.World journal of surgical oncology · 2025Article
- Artificial intelligence for detection and characterization of focal hepatic lesions: a review.Abdominal radiology (New York) · 2025Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatic hemangioma (HH) is the most common benign liver tumor and it is usually found incidentally during radiological studies. This tumor arises from a vascular malformation; however, the pathophysiology has not been clearly elucidated. Symptoms usually correlate with the size and location of the tumor. Less commonly the presence of a large HH may cause life-threatening conditions. The diagnosis can be established by the identification of HH hallmarks in several imaging studies. In patients that present with abdominal symptoms other etiologies should be excluded first before attributing HH as the cause. In asymptomatic patient's treatment is not required and follow up is usually reserved for HH of more than 5 cm. Symptomatic patients can be managed surgically or with other non-surgical modalities such as transcatheter arterial embolization or radiofrequency ablation. Enucleation surgery has shown to have fewer complications as compared to hepatectomy or other surgical techniques. Progression of the tumor is seen in less than 40%. Hormone stimulation may play a role in HH growth; however, there are no contraindications for hormonal therapy in patients with HH due to the lack of concrete evidence. When clinicians encounter this condition, they should discern between observation and surgical or non-surgical management based on the clinical presentation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.